We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+7.97%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.3B
AUM Growth
+$1.17B
(+4.5%)
Cap. Flow
-$1B
Cap. Flow
% of AUM
-3.68%
Top 10 Holdings %
Top 10 Hldgs %
13.33%
Holding
1,440
New
99
Increased
518
Reduced
438
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$58.6M |
| 2 |
Charter Communications
CHTR
|
+$45.8M |
| 3 |
Credit Acceptance
CACC
|
+$44.9M |
| 4 |
Home Depot
HD
|
+$43M |
| 5 |
Autodesk
ADSK
|
+$40.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$77.5M |
| 2 |
Apple
AAPL
|
+$73.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$64.7M |
| 4 |
Merck
MRK
|
+$58.9M |
| 5 |
Qualcomm
QCOM
|
+$56.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 16.1% |
| 3 | Financials | 11.41% |
| 4 | Consumer Discretionary | 10.23% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
451
DELISTED
Loxo Oncology, Inc
LOXO
| $10.6M | 0.04% |
61,900
-4,700
| -7% | -$790K |
|
452
Diamondback Energy
FANG
$59.2B
| $10.5M | 0.04% |
77,593
-4,494
| -5% | -$573K |
|
|
CBIO
453
Crescent Biopharma
CBIO
$698M
| $10.5M | 0.04% |
7,258
+1,129
| +18% | +$1.71M |
|
454
Integer Holdings
ITGR
$4.29B
| $10.4M | 0.04% |
125,900
-7,300
| -5% | -$547K |
|
455
Groupon
GRPN
$762M
| $10.4M | 0.04% |
138,212
+25,117
| +22% | +$2.21M |
|
456
Akamai
AKAM
$15.1B
| $10.4M | 0.04% |
+142,178
| New | +$10.7M |
|
|
PDCO
457
DELISTED
Patterson Companies, Inc.
PDCO
| $10.2M | 0.04% |
419,200
-15,400
| -4% | -$365K |
|
458
Brixmor Property Group
BRX
$8.7B
| $10.2M | 0.04% |
584,830
+78,731
| +16% | +$1.39M |
|
459
Cummins
CMI
$74.1B
| $10.2M | 0.04% |
69,706
-600
| -0.9% | -$84.5K |
|
460
Yum China
YUMC
$14.2B
| $10.2M | 0.04% |
289,639
-78,657
| -21% | -$2.8M |
|
461
Assured Guaranty
AGO
$3.14B
| $10.1M | 0.04% |
238,700
-20,700
| -8% | -$822K |
|
462
PENN Entertainment
PENN
$2.38B
| $10M | 0.04% |
305,000
+96,000
| +46% | +$3.19M |
|
463
Greif
GEF
$4.63B
| $9.94M | 0.04% |
185,300
-15,900
| -8% | -$864K |
|
|
SIVB
464
DELISTED
SVB Financial Group
SIVB
| $9.92M | 0.04% |
31,918
+29,100
| +1,033% | +$9.18M |
|
465
Mettler-Toledo International
MTD
$26.7B
| $9.87M | 0.04% |
16,206
+2,700
| +20% | +$1.59M |
|
|
SAGE
466
DELISTED
Sage Therapeutics
SAGE
| $9.83M | 0.04% |
69,570
-100
| -0.1% | -$15.4K |
|
|
NUAN
467
DELISTED
Nuance Communications, Inc.
NUAN
| $9.79M | 0.04% |
653,037
-128,783
| -16% | -$1.78M |
|
|
COL
468
DELISTED
Rockwell Collins
COL
| $9.79M | 0.04% |
69,695
-3,300
| -5% | -$454K |
|
469
Deluxe
DLX
$1.08B
| $9.74M | 0.04% |
171,000
-22,400
| -12% | -$1.35M |
|
470
Radian Group
RDN
$4.68B
| $9.72M | 0.04% |
470,100
+122,300
| +35% | +$2.35M |
|
471
Popular Inc
BPOP
$10.5B
| $9.61M | 0.04% |
187,500
+124,700
| +199% | +$6.21M |
|
472
TherapeuticsMD
TXMD
$25M
| $9.6M | 0.04% |
29,265
+8,024
| +38% | +$2.46M |
|
473
Idexx Laboratories
IDXX
$40.2B
| $9.58M | 0.04% |
38,371
+5,100
| +15% | +$1.24M |
|
474
ON Semiconductor
ON
$28.5B
| $9.58M | 0.04% |
519,688
-408,800
| -44% | -$8.74M |
|
475
CenterPoint Energy
CNP
$25B
| $9.57M | 0.04% |
346,129
+253,800
| +275% | +$7.11M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q3 2018 Portfolio in Review
As of Q3 2018, Axa held 1,440 positions worth $27.3B, up 4.5% from $26.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Axa withdrew a net $1B in Q3 2018, closing 115 positions and reducing 438 holdings. Its most notable exit was CA, Inc., an estimated $56.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in KKR & Co worth $27.3M.
- Axa's largest Q3 2018 buy was KKR & Co: 1,000,000 shares worth $27.3M.
- Axa added most to Intel in Q3 2018, an estimated $58.6M increase.
- Axa's biggest Q3 2018 reduction was DexCom, cutting an estimated $77.5M.
- Axa fully exited CA, Inc. in Q3 2018, selling an estimated $56.1M.
- Axa's ten largest holdings make up 13% of its $27.3B portfolio in Q3 2018.
- Axa opened 99 new positions and closed 115 in Q3 2018.
- Axa's portfolio value rose 4.5% quarter-over-quarter to $27.3B.
Based on Axa's 13F filing for Q3 2018, filed 8 Nov 2018.